Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Advertising and marketing

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Chewy

Chewy, Inc. operates as a pure-play pet e-tailer in the United States. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Dania Beach, FL.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Chewy reports strong Q1 earnings, raises full-year outlook

Chewy's Q1 performance reflects strong net sales growth and margin expansion, driven by Autoship sales and improved gross margin. The company is optimistic about its expansion into Canada and the potential of Lemonade in Chewy Health. However, challenges related to freight costs and potential macro issues may impact future performance.

Chewy reports $2.78B in Q2 net sales, eyes Canadian expansion

Chewy's Q2 2023 earnings call highlighted strong net sales growth, successful initiatives in the Chewy Health platform, and upcoming expansion into the Canadian market. The company is prepared to navigate potential challenges in changing consumer behavior and promotional activity while focusing on driving customer engagement and strategic expansion.

Chewy reports strong Q3 performance, eyes growth in Canada

Chewy's Q3 performance reflects solid growth, particularly in pharmacy sales and customer acquisition during key shopping events. While facing challenges in customer management and strategic planning, the company's expansion into Canada and focus on enhancing customer value present promising opportunities for future growth.

Chewy reports robust Q4 earnings, eyes international expansion for growth

Chewy delivered strong Q4 performance with increased net sales and gross margin expansion, positioning for continued growth in 2023 through supply chain initiatives and margin improvement strategies.
While facing challenges in discretionary categories and market competitiveness, Chewy's focus on international expansion and gross margin expansion presents significant growth opportunities.
The company's emphasis on operational efficiency, customer growth, and margin enhancement underscores its commitment to sustainable growth and profitability in the evolving retail landscape.

Chewy excels in Q1 with strong sales growth and strategic expansions

Chewy's Q1 results showcase strong sales growth, margin efficiency, and strategic expansions. The company remains optimistic about revenue potential, consumer engagement, and operational enhancements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Bank of America

B2Gold

Canaan Inc.

Carnival

First Solar

General Motors

While inflation may have been the theme of 2022, disinflation could be the defining label for the outgoing year, thus warranting a closer examination of stocks to buy for lower interest rates. To be sure, you want to be careful about betting too heavily on the monetary policy pivot.

7 Stocks to Buy if the Fed Goes Through With Interest Rate Cuts

Freshpet

Zoetis

Pet care stocks are incredibly effective in diversifying investment portfolios, leveraging the robust growth of the pet care industry. The sector's expansion is evident.

Pet Care Profits: 3 Stocks Benefitting from the Pet Boom

The FED has started to hint its new dovish stance to the markets, with the possibility of up to six rate cuts coming to you in 2024. What this means for markets, well, that could take longer than you intend to stay and read on the best strategies out there, so stick with that: the best strategies.

Looking for growth? It's here, 2 stocks you could finally own

Affirm

FedEx

Here's our daily look at three charts linked to recent news-driven price moves, with key technical levels to eye.

3 Charts For Investors to Watch Wednesday: FedEx, Chewy, Affirm

Chewy Inc (NYSE: CHWY) has had a terrible 2023 but the coming year will likely be a different story altogether, says Kaumil Gajrawala – a Jefferies analyst.

Chewy stock outlook: Jefferies sees upside to $27

Pet supplies and trips to the vet aren't getting any cheaper. But as higher prices raise questions about the impact on demand, analysts at Jefferies said online retailer Chewy Inc. and pet-medication distributor PetIQ Inc. were best positioned for the more cautious backdrop, thanks to wealthier customers and a more proactive approach to pet health.

Higher prices are squeezing pet owners. Analysts say this online retailer ‘appears insulated.

Shares of online pet products retailer Chewy (NYSE: CHWY ) are jumping conspicuously higher on an otherwise slow Tuesday on Wall Street. Amplifying the positive sentiment is fresh analyst coverage of CHWY stock accompanied with a “buy” rating.

Chewy (CHWY) Stock Just Scored a New ‘Buy' Rating

Petco Health and Wellness

The analysts started coverage of both pet goods stocks on Monday.

Buy Chewy, Hold Petco, Jefferies Argues. Both Stocks Are Higher.

Ginkgo Bioworks Holdings

Etsy

Intellia Therapeutics

Teladoc

These stocks are down but not out -- thanks to their solid long-term prospects. This list includes healthcare innovators and two exciting e-commerce companies.

5 Beaten-Down Stocks That Could Soar in 2024

Pet products retailer Chewy is launching “Chewy Vet Care,” a network of pet health practices. The first of these veterinary practices will open in South Florida in early 2024, with more to come as the year goes on, offering services including routine appointments, urgent care and surgery, the company said in a Thursday (Dec. 14) news release.

Chewy Launches Vet Service as Consumers Keep Spending on Pets

Chewy and eight other companies have been warned that it is violating federal law by selling or making unapproved antibiotics for animals that regulators fear could contribute to the growth of so-called drug-resistant superbugs.  The Food and Drug Administration sent letters to the companies on Thursday warning them against selling products that contain the antibiotics amoxicillin and penicillin, according to reports.

Chewy is breaking the law by selling unapproved antibiotics, FDA warns

PLANTATION, Fla.--(BUSINESS WIRE)--Chewy, Inc. (NYSE: CHWY) (“Chewy”), whose mission is to be the most trusted and convenient destination for pet parents and partners, everywhere, today announced the launch of its pet health practices under the brand name “Chewy Vet Care.” The first practice will open in South Florida early next year with additional locations launching throughout 2024, and offer services including routine appointments, urgent care and surgery. The practices will be powered by C.

Chewy to Open Its First Veterinary Practices with Launch of Chewy Vet Care

Chewy and eight other companies are violating federal law by selling or making unapproved antibiotics and other antimicrobial drugs for animals that could potentially give rise to drug-resistant superbugs, the U.S. health regulator said.

US FDA warns Chewy, others over selling unapproved animal antibiotics

Chewy continues to generate more revenue from its Autoship program. Its customer base is shrinking, and the business is being negatively impacted by macro headwinds.

Chewy Stock: Bull vs. Bear

Apple

Alphabet

Top technology companies Alphabet and Apple still look cheap, even after this year's gains. E-commerce stock Chewy reached the big milestone of profitability last year -- and a new catalyst lies ahead.

Got $1,000? 4 Stocks to Buy Now While They're on Sale.

Chewy reported better-than-expected earnings for Q3, with high-single digit top line growth, solid EBITDA margins and positive free cash flow. The company's revenue trajectory is positive, with customers spending more on their pets and net sales per active customer increasing. Chewy's focus on the passionate pet niche translates to attractive growth potential.

Chewy: Set For A Rebound

Pfizer

Pfizer is in the middle of its biggest streak of product launches ever. Teladoc Health launched an operational review of its business to accelerate the path to profitability.

3 Dirt Cheap Stocks That Make Terrific Buys Before the End of the Year

SentinelOne

Toast

Toast is disrupting the restaurant software industry with great technology and a customer-first mindset. This cybersecurity leader continues to report robust growth, and the stock is starting to respond.

Looking for Next Year's Winners? These Underdog Growth Stocks Are Great Buys for 2024 and Beyond

Amazon

Home Depot

Coca-Cola

Most of these names, such as Amazon and Apple, are familiar for one good reason: They've proven themselves over time. And these market giants still have what it takes to boost your portfolio over time.

5 No-Brainer Stocks to Buy Before 2024

The pet goods specialist released its fiscal third-quarter results after the close of trading Wednesday. It missed on both the top and bottom lines.

Why Investors Punished Chewy Stock on Thursday

PetMed Express

Pet stocks are an exciting way to diversify your portfolio. These companies ride high on the tailwinds of the pet care industry, which took many analysts by surprise.

3 Promising Stocks to Buy in the Booming Pet Tech Industry

Dollar General

Shares of retail companies Chewy Inc (NYSE:CHWY) and Dollar General Corp (NYSE:DG) are both moving lower this afternoon following their respective quarterly earnings reports, and both equities are seeing unusual intraday options volume as well.

Options Traders Target 2 Retail Stock After Earnings

Chewy Inc shares fell Thursday morning despite the company's third-quarter earnings beating expectations after its guidance failed to impress.   The pet products e-commerce company posted adjusted earnings of $0.15 per share, better than the $0.06 per share loss expected by analysts.

Chewy's 4Q guidance falls short of expectations as pet adoptions fall year-over-year

Chewy, Inc. (NYSE:CHWY ) Q3 2023 Earnings Call Transcript December 6, 2023 5:00 PM ET Company Participants Jen Hsu - Head of IR Sumit Singh - CEO Stacy Bowman - Interim CFO Conference Call Participants Eric Sheridan - Goldman Sachs Douglas Anmuth - JPMorgan Nathan Feather - Morgan Stanley Anna Andreeva - Needham Rick Patel - Raymond James Steven Zaccone - Citi Brian Fitzgerald - Wells Fargo Steven Forbes - Guggenheim Lee Horowitz - Deutsche Bank Rupesh Parikh - Oppenheimer Operator Hello, everyone. Thank you for attending today's Chewy Third Quarter 2023 Earnings Call.

Chewy, Inc. (CHWY) Q3 2023 Earnings Call Transcript

This retail season, the spotlight is on customer value, and Chewy is serving it up to its customers who foot the bill for their furry companions — also cherished customers.

News for Chewy Stock (CHWY)